Icosavax Inc.

NASDAQ: ICVX · Real-Time Price · USD
15.31
-0.14 (-0.91%)
At close: Feb 16, 2024, 10:00 PM

Icosavax Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
58.85M 279.08M
Short-Term Investments
159.46M n/a
Long-Term Investments
n/a n/a
Other Long-Term Assets
-14.76M -1.08M
Receivables
n/a n/a
Inventory
n/a n/a
Other Current Assets
4.54M 5.83M
Total Current Assets
223.91M 286.55M
Property-Plant & Equipment
14.76M 1.08M
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
14.76M 1.08M
Total Assets
238.68M 287.63M
Account Payables
2.89M 3.9M
Deferred Revenue
n/a 582K
Short-Term Debt
2.14M n/a
Other Current Liabilities
8.76M 4.76M
Total Current Liabilities
13.79M 9.24M
Long-Term Debt
6.66M n/a
Other Long-Term Liabilities
69K 171K
Total Long-Term Liabilities
6.73M 171K
Total Liabilities
20.52M 9.41M
Total Debt
8.79M n/a
Common Stock
6K 5K
Retained Earnings
-185.83M -94.07M
Comprehensive Income
-403K -287.63M
Shareholders Equity
218.16M 278.22M
Total Investments
159.46M n/a